Selling PriceIf we get approval and first of its kind, better than all the rest of tests out there...
I hope we sell high right off the bat. I dont make sense to sell cheap. Awhlie back Rob did mention $30 a device to start off, I hope were not selling cheaper than that, considering the tests out there are way above $100 per test.
Plus no one even mentions their Antiboday test kits? Add that to the Venowave revenue.
Hopefully after approval, immediately followed by contracts we see a nice spike. Plus, if they remove the swab tests (PCR i believe) by the new year and were one of the company still standing, I might be dreaming, but why not $25 a share